FDC
|
The Current P/E Ratio of FDC is 20.35.
| Share Price | ₹391.7 | Nov 05,2026 |
| Market Cap | ₹6,376.1 Cr | |
| Earnings-TTM | ₹313.2 Cr | TTM-Consolidated Results |
| Price/Earnings | 20.35x | Calculated as Market Cap/Earnings |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PE (Price/Earnings) ratio of FDC
P/E =
Market Capitalization
/ Net Income
or, using per-share numbers:
P/E = Stock Price /
Earnings Per Share (EPS)
Current Market Cap [ ₹6,376.1 Cr] as on Nov 05,2026
(/) Earnings [ ₹313.2 Cr] based on TTM-Consolidated Results
(=) P/E Ratio [ 20.35x ]
Thus, for FDC , the investors are currently willing to pay 20.35 times earnings to own 1 share of the company.
PE Multiples are the most widely used valuation multiple in practice.
Since P/E ratio uses Net Income in the calculation, P/E multiples are not always reliable for valuing companies with negative earnings.
In such cases, you may consider using Price to Book ratio or Price to Sales ratio of FDC !
P/E ratios, also, would not adjust for differences in the capital structure between companies.
The chart below summarizes the trend in P/E Ratio of FDC over the last five years.
Historical PE (Price/Earnings) ratio chart of FDC
PE Ratio Performance Analysis for FDC
- FDC 's p/e ratio for fiscal years ending Mar2026 to Mar2022 averaged 21.46x.
- FDC 's operated at median p/e ratio of 21.94x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, FDC 's p/e ratio peaked in Mar2025 at 24.06x.
- FDC 's p/e ratio hit its five-year low in Mar2026 of 18.58x.
How does FDC 's P/E Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Earnings-TTM (Cr) | PE Ratio | Market Cap |
|---|---|---|---|
| FDC | 313.25 | 20.35 | 6,376.1 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 11,037.20 | 39.68 | 437,963.0 |
| DIVIS LABORATORIES LTD | 2,925.00 | 92.12 | 269,451.0 |
| TORRENT PHARMACEUTICALS LTD | 2,099.00 | 85.50 | 179,456.0 |
| CIPLA LTD | 2,868.29 | 39.48 | 113,246.0 |
| DR REDDYS LABORATORIES LTD | 2,759.70 | 41.19 | 113,664.0 |
| MANKIND PHARMA LTD | 2,249.69 | 46.18 | 103,881.0 |
| LUPIN LTD | 5,221.47 | 17.41 | 90,887.0 |
| ZYDUS LIFESCIENCES LTD | 4,159.00 | 28.69 | 119,341.0 |
| AUROBINDO PHARMA LTD | 3,993.05 | 25.77 | 102,895.0 |
| LAURUS LABS LTD | 1,333.75 | 95.00 | 126,703.0 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PE Analysis vs FDC 's P/E Ratio
| Top 10 Industry Peers | PE Ratio |
|---|---|
| Min industry PE | 17.41x |
| Max industry PE | 95.00x |
| Median industry PE | 39.68x |
| Average industry PE | 48.31x |
You may also like the below Video Courses